loading

Newamsterdam Pharma Company N V Stock (NAMSW) Forecast

The Newamsterdam Pharma Company N V (NAMSW) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $5.2245, representing a -38.54% decrease from the current price of $8.50. The highest analyst price target is $5.6863, and the lowest is $4.7627.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NAMSW Price Target
Average 5.8241 (-31.48% Downside)
loading

Is Newamsterdam Pharma Company N V (NAMSW) A Buy Now?

Oscillators
Name Value Action
RSI(14) 30.30 Neutral
STOCH(9,6) 18.92 Buy
STOCHRSI(14) 17.92 Buy
MACD(12,26) -1.1138 Sell
ADX(14) 27.52 Sell
William %R -95.30 Buy
CCI(14) -72.86 Neutral
Buy: 3 Sell: 2 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
9.6943
Sell
9.6957
Sell
MA20
11.70
Sell
10.82
Sell
MA50
11.77
Sell
11.24
Sell
MA100
9.9576
Sell
10.60
Sell
MA200
9.7905
Sell
9.7859
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, NAMSW could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on NAMSW, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 30.3 indicates that NAMSW is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 18.92 indicates that NAMSW is oversold. This indicates that NAMSW price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 17.92 indicates that NAMSW is oversold. This suggests that NAMSW price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 27.52 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -72.86 indicates that NAMSW is still oversold but not to an extreme extent.

Long-term NAMSW price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Newamsterdam Pharma Company N V financial reports and earnings history, Newamsterdam Pharma Company N V (NAMSW) stock could reach $13.05 by 2030, $87.03 by 2040 and $173.84 by 2050. See the projected annual prices until 2050 of the Newamsterdam Pharma Company N V stock below:

  • Newamsterdam Pharma Company N V (NAMSW) is expected to reach an average price of $34.29 in 2035, with a high prediction of $41.15 and a low estimate of $35.29. This indicates an $303.37% rise from the last recorded price of $8.50.
  • Newamsterdam Pharma Company N V (NAMSW) stock is projected to chart a bullish course in 2040, with an average price target of $69.41, representing an $716.63% surge from its current level. The forecast ranges from a conservative $72.28 to a sky-high $87.03.
  • Our analysts predict Newamsterdam Pharma Company N V (NAMSW) to jump 1,275% by 2045, soaring from $120.15 to an average price of $116.89, potentially reaching $139.64. While $120.15 is the low estimate, the potential upside is significant.
  • Newamsterdam Pharma Company N V (NAMSW) stock is expected to climb by 2050, reaching an average of $173.85, a $1,945% jump from its current level. However, a wide range of estimates exists, with high and low targets of $173.84 and $6.5545, respectively, highlighting the market's uncertainty.

Newamsterdam Pharma Company N V Stock (NAMSW) Year by Year Forecast

Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2025

Newamsterdam Pharma Company N V Stock (NAMSW) is expected to reach an average price of $5.7025 in 2025, with a high prediction of $11.14 and a low estimate of $0.2618. This indicates an -32.91% fall from the last recorded price of $8.50.
Month Average Low High Change from today's price
March, 2025 $4.4042 $4.7627 $5.6863 -48.19%
April, 2025 $3.1318 $0.2618 $8.0632 -63.16%
May, 2025 $6.515 $3.0591 $9.965 -23.35%
June, 2025 $7.9795 $6.1123 $9.3409 -6.12%
July, 2025 $8.9528 $7.4955 $10.75 +5.33%
August, 2025 $6.9951 $7.3536 $8.5363 -17.70%
September, 2025 $1.0591 $0.8091 $5.8609 -87.54%
October, 2025 $5.09 $1.2455 $8.54 -40.12%
November, 2025 $7.0727 $4.9464 $8.3045 -16.79%
December, 2025 $7.8455 $6.9773 $10.37 -7.70%

Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2026

The predicted value for Newamsterdam Pharma Company N V (NAMSW) in 2026 is set at an average of $8.5829. Estimates vary from a peak of $17.09 to a trough of $0.0795, indicating an +0.98% surge from the present price of $8.50.
Month Average Low High Change from today's price
January, 2026 $9.586 $8.2136 $11.39 +12.78%
February, 2026 $1.0136 $3.0114 $5.8068 -88.07%
March, 2026 $3.8773 $0.0795 $4.2273 -54.39%
April, 2026 $6.1659 $0.4597 $7.2682 -27.46%
May, 2026 $7.4568 $6.4591 $9.9773 -12.27%
June, 2026 $13.19 $7.9545 $14.24 +55.21%
July, 2026 $3.0864 $5.2136 $12.18 -63.69%
August, 2026 $2.3227 $0.1727 $2.6727 -72.67%
September, 2026 $4.2918 $0.9653 $6.2318 -49.51%
October, 2026 $7.0682 $4.8891 $9.5887 -16.84%
November, 2026 $15.91 $7.6955 $17.09 +87.21%
December, 2026 $5.1591 $7.4159 $14.77 -39.30%

Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Newamsterdam Pharma Company N V (NAMSW) is $11.53, with a high forecast of $22.79 and a low forecast of $0.2827. This indicates an +35.70% increase from the last price of $8.50.
Month Average Low High Change from today's price
January, 2027 $0.7682 $1.3818 $4.2323 -90.96%
February, 2027 $3.2555 $1.4486 $5.1955 -61.70%
March, 2027 $6.8327 $3.9823 $6.8327 -19.61%
April, 2027 $18.63 $6.2795 $19.94 +119.22%
May, 2027 $5.1182 $9.6182 $17.36 -39.79%
June, 2027 $3.9727 $4.9727 $6.1755 -53.26%
July, 2027 $2.2191 $0.2827 $4.1591 -73.89%
August, 2027 $6.3145 $3.0755 $6.3145 -25.71%
September, 2027 $21.35 $5.8909 $22.79 +151.22%
October, 2027 $7.3205 $11.82 $19.95 -13.88%
November, 2027 $5.6568 $6.6568 $8.1186 -33.45%
December, 2027 $1.1827 $0.3409 $3.1227 -86.09%

Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2028

In 2028, Newamsterdam Pharma Company N V (NAMSW) is projected to reach an average price of $15.85, with a high projection of $31.34 and a low estimate of $0.355. This indicates an +86.42% rise from the last price of $8.50.
Month Average Low High Change from today's price
January, 2028 $5.7964 $2.1686 $5.7964 -31.81%
February, 2028 $25.65 $5.5023 $25.64 +201.76%
March, 2028 $9.5227 $14.02 $24.07 +12.03%
April, 2028 $7.3409 $8.3409 $10.06 -13.64%
May, 2028 $2.0491 $0.9545 $3.5455 -75.89%
June, 2028 $5.2782 $0.3836 $5.2782 -37.90%
July, 2028 $28.50 $5.1136 $28.49 +235.29%
August, 2028 $11.72 $16.22 $26.80 +37.94%
September, 2028 $9.025 $10.02 $12.01 +6.18%
October, 2028 $3.215 $2.25 $5.10 -62.18%
November, 2028 $4.76 $0.355 $4.76 -44.00%
December, 2028 $31.35 $4.725 $31.34 +268.82%

Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2029

The 2029 price forecast for Newamsterdam Pharma Company N V Stock (NAMSW) is $18.76 on average, with a high prediction of $37.04 and a low estimate of $0.4755. This represents an +120.66% increase from the previous price of $8.50.
Month Average Low High Change from today's price
January, 2029 $20.20 $24.04 $29.52 +137.67%
February, 2029 $12.90 $13.26 $13.95 +51.81%
March, 2029 $4.3809 $3.5455 $9.6791 -48.46%
April, 2029 $2.7873 $0.5518 $3.0873 -67.21%
May, 2029 $34.20 $2.8318 $34.19 +302.35%
June, 2029 $22.53 $26.37 $32.24 +165.10%
July, 2029 $14.72 $15.08 $15.89 +73.14%
August, 2029 $5.5468 $4.8409 $11.36 -34.74%
September, 2029 $2.1395 $0.4755 $2.4395 -74.83%
October, 2029 $5.2227 $2.3136 $8.1318 -38.56%
November, 2029 $24.87 $28.70 $37.04 +192.53%
December, 2029 $16.53 $16.89 $17.83 +94.48%

Newamsterdam Pharma Company N V Stock (NAMSW) Price Forecast for 2030

Newamsterdam Pharma Company N V Stock (NAMSW) is expected to reach an average price of $21.52 in 2030, with a high forecast of $42.74 and a low forecast of $0.3018. This signifies an +153.17% surge from the last price of $8.50.
Month Average Low High Change from today's price
January, 2030 $6.7127 $6.1364 $13.05 -21.03%
February, 2030 $1.4918 $0.3018 $2.0591 -82.45%
March, 2030 $4.8341 $1.7955 $7.8727 -43.13%
April, 2030 $30.74 $34.01 $39.89 +261.65%
May, 2030 $18.34 $18.70 $26.48 +115.82%
June, 2030 $7.2818 $7.4318 $14.73 -14.33%
July, 2030 $0.6191 $1.0791 $5.3186 -92.72%
August, 2030 $3.9739 $0.3341 $7.6136 -53.25%
September, 2030 $33.20 $36.47 $42.74 +290.61%
October, 2030 $20.16 $20.52 $28.81 +137.16%
November, 2030 $8.5773 $8.7273 $16.42 +0.91%
December, 2030 $1.3964 $1.8564 $6.4845 -83.57%
$79.78
price down icon 0.06%
$32.30
price up icon 0.22%
$4.7701
price up icon 7.86%
$365.18
price up icon 3.26%
biotechnology ONC
$221.81
price up icon 0.18%
$112.58
price down icon 1.68%
Cap:     |  Volume (24h):